MarketCap
Facebook
X
Telegram
Amryt Pharma plc ROCE | AMYT
ROCE Jährlich Amryt Pharma plc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.86 | -10.67 | -11.88 | -26.23 | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -5.86 | -26.23 | -13.66 |
ROCE Vierteljährlich Amryt Pharma plc
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -28.41 | -28.41 | -28.41 | -28.41 | 459.47 | 465.33 | 465.33 | 465.33 | -10.67 | - | - | - | -11.88 | - | - | - | 487.88 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 487.88 | -28.41 | 200.65 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Eiger BioPharmaceuticals
EIGR
|
496.51 | - | -9.21 % | $ 2.55 M |  USA |
 |
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | USA |
 |
BELLUS Health
BLU
|
-19.87 | - | - | $ 2.47 B |  Canada |
 |
bluebird bio
BLUE
|
857.68 | - | - | $ 546 M | USA |
 |
Intra-Cellular Therapies
ITCI
|
-10.16 | - | - | $ 13.6 B | USA |
 |
IGM Biosciences
IGMS
|
-432.99 | - | - | $ 76.9 M | USA |
 |
Marinus Pharmaceuticals
MRNS
|
-784.28 | - | - | $ 29.6 M | USA |
 |
Merrimack Pharmaceuticals
MACK
|
-10.87 | - | - | $ 216 M | USA |
 |
CASI Pharmaceuticals
CASI
|
-76.35 | - | - | $ 35.4 M | USA |
 |
ContraFect Corporation
CFRX
|
545.12 | - | -5.16 % | $ 5.39 M | USA |
 |
Sigilon Therapeutics
SGTX
|
-111.56 | - | - | $ 728 M | USA |
 |
Rubius Therapeutics
RUBY
|
-1179.34 | - | -33.55 % | $ 7.81 M | USA |
 |
Aptinyx
APTX
|
-163.42 | - | -39.0 % | $ 4.57 M | USA |
 |
TRACON Pharmaceuticals
TCON
|
1146.23 | - | -1.38 % | $ 46.8 M | USA |
 |
Mirati Therapeutics
MRTX
|
-76.22 | - | - | $ 3.3 B | USA |
 |
Revance Therapeutics
RVNC
|
208.95 | - | - | $ 309 M | USA |
 |
Allogene Therapeutics
ALLO
|
-71.55 | $ 0.93 | -11.99 % | $ 205 M | USA |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
-67.64 | - | -37.48 % | $ 476 K | USA |
 |
Epizyme
EPZM
|
1150.39 | - | - | $ 249 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-1339.01 | - | -9.72 % | $ 5.89 M | USA |
 |
ORIC Pharmaceuticals
ORIC
|
-37.21 | $ 8.9 | -3.63 % | $ 781 M | USA |
 |
Forward Pharma A/S
FWP
|
-5.47 | - | -0.75 % | $ 18.7 M |  Danmark |
 |
Orchard Therapeutics plc
ORTX
|
-129.33 | - | 1.02 % | $ 90.8 M |  Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
-32.71 | - | - | $ 154 M | USA |
|
Oyster Point Pharma
OYST
|
-97.1 | - | - | $ 300 M | USA |
 |
Nabriva Therapeutics plc
NBRV
|
-1333.89 | - | - | $ 4.55 M |  Irlanda |
 |
Intercept Pharmaceuticals
ICPT
|
-20.32 | - | - | $ 643 M | USA |
 |
NGM Biopharmaceuticals
NGM
|
-101.9 | - | - | $ 127 M | USA |
 |
Regulus Therapeutics
RGLS
|
-65.49 | - | - | $ 155 M | USA |
 |
9 Meters Biopharma
NMTR
|
-1750.31 | - | -42.97 % | $ 1.05 M | USA |
 |
Chinook Therapeutics
KDNY
|
-41.88 | - | - | $ 2.6 B | USA |
 |
Lumos Pharma
LUMO
|
-134.09 | - | - | $ 35.3 M | USA |
 |
Syros Pharmaceuticals
SYRS
|
-774.14 | - | -8.44 % | $ 3.4 M | USA |
 |
NanoViricides
NNVC
|
-95.66 | $ 1.44 | 8.27 % | $ 29.1 M | USA |
 |
Gamida Cell Ltd.
GMDA
|
-46.52 | - | -18.25 % | $ 5.04 M |  Israel |
 |
GT Biopharma
GTBP
|
-214.65 | $ 3.99 | -7.64 % | $ 22 M | USA |
 |
Aravive
ARAV
|
-664.7 | - | -13.39 % | $ 1.45 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
-883.35 | - | -74.18 % | $ 955 K | USA |
 |
BioLineRx Ltd.
BLRX
|
-35.74 | $ 1.52 | -3.8 % | $ 3.75 B | Israel |
 |
VistaGen Therapeutics
VTGN
|
-203.06 | $ 0.18 | -0.46 % | $ 6.85 M | USA |
 |
C4 Therapeutics
CCCC
|
-35.34 | $ 3.0 | -4.76 % | $ 249 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-146.69 | $ 1.67 | -0.6 % | $ 2.75 M | Israel |
 |
Cytokinetics, Incorporated
CYTK
|
-50.1 | $ 56.2 | 1.92 % | $ 6.75 M | USA |
 |
Curis
CRIS
|
-104.6 | $ 0.66 | -5.68 % | $ 8.69 M | USA |
 |
Exelixis
EXEL
|
35.76 | $ 71.0 | -1.04 % | $ 19.3 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | USA |
 |
Amgen
AMGN
|
104.87 | $ 465.26 | 0.01 % | $ 250 B | USA |
 |
Biogen
BIIB
|
14.56 | $ 253.37 | -0.59 % | $ 37.1 B | USA |
 |
Edesa Biotech
EDSA
|
-63.54 | $ 2.01 | -19.28 % | $ 11.4 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
95.22 | $ 15.12 | -0.72 % | $ 978 M | USA |